Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

GABA-based drug for anxiety enters phase I

Aug. 8, 1997

NMDA antagonist enters phase I for epilepsy

Aug. 7, 1997

New analgesic/antiinflammatory compounds from Korea

Aug. 7, 1997

Results of RPR Gencell's gene therapy for Parkinson's disease reported

Aug. 7, 1997

Pain management: How to take control

Aug. 7, 1997

FDA approves first novel treatment for tremor in 30 years

Aug. 6, 1997

Dopamine D4 antagonist reported by Yamanouchi

Aug. 6, 1997

Efficacy of sumatriptan evaluated in children

Aug. 5, 1997

Zeneca invests in zolmitriptan manufacturing in Puerto Rico

Aug. 5, 1997

Sanofi compounds with potent and selective affinity for CB2 receptors

Aug. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...